Limitations of the so-called "intensified" insulin therapy in type 1 diabetes mellitus

Diabetes and Metabolism

Volumn 31, Issue 4 II, 2005, Pages

  Jacqueminet, S ^a   Masseboeuf N ^a   Rolland, M ^a   Grimaldi, A ^a   Sachon, C ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Brittle diabetes; Denial of the disease; Depression; Eating disorders; Functional insulin therapy; Hypoglycemia; Loss of control

Indexed keywords

GLUCOSE; INSULIN GLARGINE; SHORT ACTING DRUG;

AUTOREGULATION; AVOIDANCE BEHAVIOR; DENIAL; DEPRESSION; DIABETES CONTROL; DOCTOR PATIENT RELATION; EATING DISORDER; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN TREATMENT; INTENSIVE CARE; PHOBIA; REVIEW; RISK FACTOR; SELF MONITORING; TREATMENT OUTCOME;

EID: 25444448024     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1262-3636(05)88267-9     Document Type: Review

References (29)

1. Grimaldi A, Sachon C, Halbron M, Sola A, Elgrably F, Slama G. Clinique et traitement. Insulinothérapie du diabète de type 1. In: «Traité de diabétologie». Flammarion Médecine-Sciences Eds, Paris, 2005, pp. 134-48.
2. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-86.
3. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus. JAMA 2002;287:2563-9.
4. Gin H, Hanaire-Broutin H. Reproducibility and variability in the action of injected insulin. Diabetes Metab 2005;31:7-13.
5. Gill G, Lucas S. Brittle diabetes characterised by recurrent hypoglycaemia. Diabetes Metab 1999;25:308-11.
6. Kiortsis DN, Filippatos TD, Elisaf MS. The effects of orlistat on metabolic parameters and other cardiovascular risk factors. Diabetes Metab 2005;31:15-22.
7. Devries JH, Snoekt FJ, Heine RJ. Persistent poor glycaemic control in adult type 1 diabetes. A closer look at the problem. Diabet Med 2004;21:1263-8.
8. Snoek FJ, Skinner TC. Psychological counselling in problematic diabetes: does it help? Diabet Med 2002;19:265-73.
9. Langewitz W, Wossmer B, Iseli J, Berger W. Psychological and metabolic improvement after and out-patient teaching program for functional intensified insulin therapy (FIT). Diabetes Res Clin Pract 1997; 37:157-64.
10. Grimaldi A, Sachon C, Hartemann-Heurtier A. Échecs du traitement du diabète de type 1. Point de vue du diabétologue. In: «Traité de diabétologie». Flammarion Médecine-Sciences Eds, Paris, 2005, pp. 227-31.
11. Lacroix A. Échecs du traitement du diabète de type 1. Point de vue du psychologue. In: «Traité de diabétologie». Flammarion Médecine-Sciences Eds; Paris, 2005, pp. 231-6.
12. Van Tilburg MAL, McCaskill CC, Lane JD, et al. Depressed mood is a factor in glycemic control in type 1 diabetes. Psychosomatic Med 2001;63:551-5.
13. Lustman PJ, De Groot M, Anderson RJ, Carney RM, Freedland KE, Clouse RE. Depression and poor glycemic control. Diabetes Care 2000;23:934-42.
14. Hepburn DA, McLeod KM, Deary IJ, Frier BM. Structural equation modeling of symptoms, awareness and fear of hypoglycemia, and personality in patients with insulin-treated diabetes. Diabetes Care 1994; 17:1273-80.
15. Cox DJ, Irvine A, Gonder-Frederick L, Nowacek G, Butterfield J. Fear of hypoglycemia: quantification, validation, and utilization. Diabetes Care 1987;10:617-21.
16. Zambanini A, Newson RB, Maisey M, Feher MD. Injection related anxiety in insulin-treated diabetes. Diabetes Res Clin Pract 1999;46: 239-46.
17. Zambanini A, Feher MD. Needle phobia in type 1 diabetes mellitus. Diabetic Med 1997;14:321-3.
18. Berlin I, Sachon C, Bisserbe JC, et al. Phobic symptoms, particularly the fear of blood and injury, are associated with poor glycemic control in type 1 diabetic adults. Diabetes Care 1997;20:176-8.
19. Rydall AC, Rodin GM, Olmsted MP, Devenyi RG, Daneman D. Disordered eating behavior and microvascular complications in young women with insulin-dependent diabetes mellitus. N Engl J Med 1997;336:1849-54.
20. Biggs MM, Basco MR, Patterson G, Raskin P. Insulin withholding for weight control in women with diabetes. Diabetes Care 1994;17:1186-9.
21. Polonsky WH, Aponte JE, Anderson BJ, Jacobson AM, Lohrer PA, Cole CF. Insulin omission in women with IDDM. Diabetes Care 1994; 17:1178-85.
22. Bryden KS, Peveler RC, Neil A, Fairburn CG, Mayou RA, Dunger DB. Eating habits, body weight, and insulin misuse. Diabetes Care 1999;22:1956-60.
23. Muller UA, Berger M, Femerling M, et al, for the ASD (The Working Group on Structured Diabetes Therapy of the German Diabetes Association). Intensified treatment and education of type 1 diabetes as clinical routine. A nationwide quality-circle experience in Germany. Diabetes Care 1999; 22 (Suppl. 2):B29-B34.
24. Jörgens V, Grüsser M, Bott U, Mühlhauser I, Berger M. Effective and safe translation of intensified insulin therapy to general internal medicine departments. Diabetologia 1993;36:99-105.
25. The Diabetes Control and Complications Trial Research Group. Hypoglycemia in the Diabetes Control and Complications Trial. Diabetes 1997;46:271-86.
26. c in patients with type 1 diabetes. Diabetes Care 2002;25:731-6.
27. Barrier P. Echecs du traitement du diabète de type 1. Vécu du diabétique insulinodépendant et causes de l'échec thérapeutique. In: «Traité de diabétologie». Flammarion Médecine-Sciences Eds, Paris, 2005, pp. 236-42.
28. Reach G. Réflexion sur la maladie chronique: une démarche physiopathologique pour comprendre la place du temps. In: «Traité de diabétologie». Flammarion Médecine-Sciences Eds, Paris, 2005, pp. 941-50.
29. Noye D, Piveteau J. Guide pratique du formateur. Concevoir, animer, évaluer une formation. INSEP Consulting Eds, Paris, 2002, pp. 188-90.